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Abstract
Cells employ multiple levels of regulation, including transcriptional and translational regulation, that drive core biological
processes and enable cells to respond to genetic and environmental changes. Small-molecule metabolites are one category
of critical cellular intermediates that can influence as well as be a target of cellular regulations. Because metabolites
represent the direct output of protein-mediated cellular processes, endogenous metabolite concentrations can closely
reflect cellular physiological states, especially when integrated with other molecular-profiling data. Here we develop and
apply a network reconstruction approach that simultaneously integrates six different types of data: endogenous metabolite
concentration, RNA expression, DNA variation, DNA–protein binding, protein–metabolite interaction, and protein–protein
interaction data, to construct probabilistic causal networks that elucidate the complexity of cell regulation in a segregating
yeast population. Because many of the metabolites are found to be under strong genetic control, we were able to employ a
causal regulator detection algorithm to identify causal regulators of the resulting network that elucidated the mechanisms
by which variations in their sequence affect gene expression and metabolite concentrations. We examined all four
expression quantitative trait loci (eQTL) hot spots with colocalized metabolite QTLs, two of which recapitulated known
biological processes, while the other two elucidated novel putative biological mechanisms for the eQTL hot spots.
Citation: Zhu J, Sova P, Xu Q, Dombek KM, Xu EY, et al. (2012) Stitching together Multiple Data Dimensions Reveals Interacting Metabolomic and Transcriptomic
Networks That Modulate Cell Regulation. PLoS Biol 10(4): e1001301. doi:10.1371/journal.pbio.1001301
Academic Editor: Andre Levchenko, Johns Hopkins University, United States of America
Received October 3, 2011; Accepted February 20, 2012; Published April 3, 2012
Copyright:  2012 Zhu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Some members of Merck were involved in generating data for this project. We note the project in no way relates to any of the core business objectives
of Merck.
Competing Interests: I have read the journal’s policy and have the following conflicts. The work was partially funded by Merck.
Abbreviations: BN, Bayesian network; eQTL, expression quantitative trait loci; FDR, false discovery rate; IMP, inosine monophosphate; metQTL, metabolite
quantitative trait loci; MS, mass spectrometry; NAc-glutamate, N-acetyl-glutamate; qNMR, quantitative nuclear magnetic resonance; TF, transcription factor
* E-mail: jun.zhu@mssm.edu (JZ); eric.schadt@mssm.edu (EES)
. These authors contributed equally to this work.
Introduction
Cells are complex molecular machines that employ multiple
levels of regulation that enable them to respond to genetic and
environmental perturbations. Advances in biology over the past
several years to elucidate the complexity of this regulation have
been truly astonishing. However, despite transformative advances
in technology, it remains difficult to assess where we are in our
understanding of cell regulation, relative to a complete compre-
hension of such a process. One of the primary difficulties in our
making such an assessment is that the suite of research tools
available to us seldom provides insights into aspects of the overall
picture of the system that are not directly measured. While
different technologies provide information that our analytical
tools, both algorithmic and intellectual, seek to combine into a
coherent picture, one of the primary limitations of the majority of
analytical tools in use today is a focus on single dimensions of data,
rather than on maximally integrating data across many different
dimensions simultaneously to view processes more completely,
thereby achieving a greater understanding of these processes.
The full suite of interacting parts in a cell over time, if they
could be viewed collectively, would enable our achieving a more
complete understanding of cellular processes, much in the same
way we achieve understanding by watching a movie. The
continuous flow of information in a movie enables our minds to
exercise an array of priors that provide context and constrain the
possible relationships (structures), while our internal network
reconstruction engine pieces all of the information together
regarding the highly complex and nonlinear relationships
represented in the movie, so that in the end we are able to
achieve an understanding of what is depicted at a hierarchy of
levels. If instead of viewing a movie as a continuous stream of
frames of coherent pixels and sound, we viewed single dimensions
of the information independently, understanding would be difficult
if not impossible to achieve. For example, consider viewing a
movie as independent, one dimensional slices through the frames
PLoS Biology | www.plosbiology.org 1 April 2012 | Volume 10 | Issue 4 | e1001301of the movie, where each slice is viewed as pixel intensities across
that one dimension changing over time (like a dynamic mass spec
trace). In this way it would be very difficult to understand the
meaning of the movie by looking at all of the one dimensional
traces independently.
Despite the complexity of biological systems, even at the cellular
level, research in the context of large-scale high dimensional -
omics data has tended to focus on single data dimensions, whether
constructing coexpression networks on the basis of gene expression
data, carrying out genome-wide association analyses on the basis
of DNA variation information, or constructing protein interaction
networks on the basis of protein–protein interaction data. While
we achieve some understanding in this way, progress is limited
because none of the dimensions on their own provide a complete
enough context within which to interpret results fully. This type of
limitation has become apparent in genome-wide association
studies (GWAS), where many hundreds of highly replicated loci
have been identified and highly replicated as associated with
disease; but our understanding of disease is still limited because the
genetic loci do not necessarily inform on the gene affected, on how
gene function is altered, or more generally, how the biological
processes involving a given gene are altered [1–4]. It is apparent
that if different biological data dimensions could be formally
considered simultaneously, we would achieve a more complete
understanding of biological systems [2,3,5–7]. (See the documen-
tary film The New Biology at http://www.youtube.com/
watch?v=sjTQD6E3lH4.)
Therefore, to form a more complete understanding of biological
systems, we must not only evolve technologies to sample systems at
ever higher rates and with ever greater breadth, we must innovate
methods that consider many different dimensions of information
to produce more descriptive models (movies) of the system.
Methods are emerging that integrate pairs of data dimensions. For
example, we recently developed methods that simultaneously
integrate DNA variation and RNA expression data generated in a
population context to identify coherent modules of interconnected
gene expression traits driven by common genetic factors [2,8]. In
addition, many groups have begun incorporating a time dimension
in the context of high-dimensional molecular-profiling data to
elucidate how networks can transform over time [9,10].
Here we develop and apply a network reconstruction approach
that simultaneously integrates six different types of data:
endogenous metabolite concentration, RNA expression, DNA
variation, DNA–protein binding, protein–metabolite interaction,
and protein–protein interaction data, to construct probabilistic
causal networks that elucidate the complexity of cell regulation
(Figure 1). The goals of our integrative analysis are not only to find
causal regulators underlying expression quantitative trait loci
(eQTL) hot spots, but to uncover mechanisms by which these
predicted causal regulators affect genes and metabolites whose
transcriptional profiles or metabolite profiles are linked to the
eQTL hot spots. We leveraged a previously described cross
between laboratory (BY) and wild (RM) yeast strains (referred to
here as the BXR cross) for which DNA variation and RNA
expression had been assessed [11,12], to carry out a quantitative
metabolite profiling using quantitative NMR (qNMR) under the
same experimental conditions as the gene expression study [12–
14]. We demonstrate that, like transcript and protein levels,
concentrations of many metabolites are strongly linked to
metabolite QTLs (metQTLs). Several of the metQTLs are seen
to colocalize with expression quantitative trait loci (eQTLs)
previously identified in the same yeast population [13], enabling
us to infer causal relationships between metabolites and expression
traits [13,14]. Then, by extending a previously described Bayesian
network (BN) reconstruction algorithm [13], we constructed a
probabilistic causal network by integrating metabolite levels,
genotype, gene expression, transcription factor (TF) binding, and
protein–protein interaction data. The resulting network not only
validates the functional importance of eQTL hot spots in the BXR
cross, but elucidates the mechanisms by which variation in DNA
at eQTL hot spots affect gene expression. By systematically using
the networks to elucidate the regulators of these eQTL hot spots,
we are not only able to recapitulate known regulatory mecha-
nisms, we are able to provide a number of novel and
experimentally supported causal relationships predicted by our
network, including that cellular amino acid concentrations are
related to both amino acid biosynthesis pathways and amino acid
degradation pathways, with VPS9 predicted and prospectively
validated as a key driver of a previously identified eQTL hot spot
that could not previously be well characterized. In addition, we
further experimentally demonstrated that PHM7, a previously
predicted and validated causal regulator for stress response genes
whose expression variations are linked to the PHM7 locus on
Chromosome XV, affected trehalose, a yeast metabolite product
of the stress response pathway. These results combined not only
help uncover the mechanisms by which gene expression profiles
are regulated by metabolite profiles, but they also confirm the
importance of gene expression in understanding system-wide
variation linked to genetic perturbations.
Results
Characterizing Metabolite Levels in a Segregating Yeast
Population
Experimental context matters for inferring causal
relationships. Two classes of data were employed to
reconstruct probabilistic causal networks: (1) DNA variation,
gene expression, and metabolite data measured in the BXR cross
(referred to here as BXR data), and (2) protein–DNA binding,
protein–protein interaction, and metabolite–protein interaction
data available from public data sources and generated
independently of the BXR cross (referred to here as non-BXR
Author Summary
It is now possible to score variations in DNA across whole
genomes, RNA levels and alternative isoforms, metabolite
levels, protein levels and protein state information,
protein–protein interactions, and protein–DNA interac-
tions, in a comprehensive fashion in populations of
individuals. Interactions among these molecular entities
define the complex web of biological processes that give
rise to all higher order phenotypes, including disease. The
development of analytical approaches that simultaneously
integrate different dimensions of data is essential if we are
to extract the meaning from large-scale data to elucidate
the complexity of living systems. Here, we use a novel
Bayesian network reconstruction algorithm that simulta-
neously integrates DNA variation, RNA levels, metabolite
levels, protein–protein interaction data, protein–DNA
binding data, and protein–small-molecule interaction data
to construct molecular networks in yeast. We demonstrate
that these networks can be used to infer causal
relationships among genes, enabling the identification of
novel genes that modulate cellular regulation. We show
that our network predictions either recapitulate known
biology or can be prospectively validated, demonstrating a
high degree of accuracy in the predicted network.
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edges in the network reflect statistically inferred causal
relationships among the expression and metabolite traits
(Methods) [13]. The non-BXR interaction data from public
sources are used to derive structure priors on the network to both
constrain the size of the search space in finding the best network
and enhance the ability to infer causal relationships between the
network nodes [13].
The BXR data in particular, directly representing the nodes and
associations in the network, require special consideration given
that relationships among genes and between genes and metabolites
may be condition specific, requiring that the expression and
metabolite data be generated under identical experimental
conditions to maximize the power to identify causal relationships.
In fact, others have shown that there are widespread interactions
between genetic and environmental factors [15]. Just as genetic
factors may predispose some populations to certain human
diseases, environmental factors like diet can also increase or
decrease the risk of disease [16–18]. Both F2 mouse [19] and rat
[20] studies demonstrate that cholesterol QTLs are dependent on
diet, and similarly for obesity-related traits [21,22].
Therefore, before profiling metabolite levels in the BXR cross,
we explored the importance of context in identifying associations
between different molecular phenotypes by examining the
expression profiles of the yeast segregants in this cross and
corresponding QTLs under glucose and ethanol growth conditions
[23]. Genetic variations (such as SNPs) give rise to variations in
phenotypes, including quantitative traits such as gene expression
and clinical traits [13,14,24]. Cis-acting (or proximal) eQTLs are
special because they represent associations between DNA
variation at a given locus where the corresponding gene physically
resides and the expression levels of the corresponding gene,
reflecting in most causes allelic differences in transcript levels
[13,24,25]. For the yeast segregants comprising the BXR cross,
expression data have been generated under glucose and ethanol
growth conditions [23]. For both expression sets the underlying
genetic perturbations in the BXR cross are identical. We identified
548 and 569 cis-eQTLs for the glucose and ethanol data,
respectively, at the p-value cutoff where less than 1 false positive
is expected genome wide. However, when the two sets of cis-
eQTLs were compared, we found that only two-thirds of the cis-
eQTLs were common, where half of the total cis-eQTLs were
unique to one of the two conditions (Figure S1a). It is worth noting
that for cis-eQTL detected in one condition, the corresponding
LOD scores in the other condition are approximately uniformly
distributed over the entire LOD score range (Figure S1b and S1c).
Figure 1. Overview of the experimental design. A cross between laboratory (BY) and wild (RM) strains of S. cerevisiae [11] was gene expression
profiled. Metabolites were profiled under the same conditions. These data were then integrated with genotype data along with information from
public databases to derive a BN. The derived network was used to analyze how cells are regulated.
doi:10.1371/journal.pbio.1001301.g001
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different conditions are not due to a lack of power to replicate a
given eQTL in the second condition, but to condition-specific
effects (medium conditions in this instance).
Even under highly similar growth conditions, we can see that
slight differences in amino acid concentrations lead to significant
changes in gene expression. For example, in the original screen of
the BXR cross [11], there were 203 gene expression traits linked to
the LEU2 locus at a 5% false discovery rate (FDR) (in this instance
the leucine concentration in the medium was 80 mg/l). In a
follow-up screen of this same cross [23], the leucine concentration
in an otherwise identical growth medium was 100 mg/l; only 57
genes with expression levels linked to the LEU2 locus were
detected in this case at a 5% FDR. Greater than 60% (36) of these
57 genes overlapped the set of 203 genes, a very significant overlap
(p=1:7|10{35) indicating common biological processes were
affected (Table S1). The smaller number of genes linked to the
LEU2 locus in the follow up dataset is consistent with the known
relationship between leucine concentrations in growth medium
and leucine biosynthesis: high levels of leucine in growth medium
represses leucine biosynthesis [26]. This result implies that
considerable differences may exist in the regulatory networks
between different growth conditions. Therefore, to reliably infer
causal relationships between variations in gene expression and
metabolite levels, it is critical to measure them under identical
conditions.
Measuring metabolite levels in the BXR cross. To
maximize the power to detect relationships between metabolite
and gene expression traits in the BXR cross, we measured
metabolite levels in cell extracts from the 120 yeast segregants
composing the cross after culturing the segregants using growth
conditions that were identical to the growth conditions used to
generate the gene expression data (Methods). Cellular metabolite
concentrations can be measured by mass spectrometry (MS) [27]
technologies or qNMR [28,29]. While MS technologies are more
sensitive and can detect low-abundance metabolites, accurate
quantification requires the addition of an internal standard for
each metabolite to be measured. This can be accomplished by
generating isotope-enriched metabolite extracts (repetitively
growing cells in medium containing isotope-enriched nutrients
such as
13C6-glucose) [27]. Quantitative LCXMS/MS analyses
are then based on isotope ratios constructed by adding unlabeled
endogenous metabolites of known amounts as internal controls,
enabling an accurate quantification of metabolite levels [27,30]. In
contrast to MS-based metabolite profiling, qNMR requires no
special sample preparation procedures, although it is less sensitive
than MS techniques. With qNMR, a single internal reference
standard in an NMR sample is sufficient to quantify all detectable
endogenous metabolites. Therefore, we generated metabolite
profiling data using qNMR in the BXR cross under the same
growth condition as the gene expression profiles were generated
(Figure 1).
Metabolite abundances are under genetic control. Each
cell extract was analyzed on a 700-MHz NMR spectrometer by
acquiring one-dimensional proton spectra. The appearance and
density of peaks in these scans (Figure S2) were in keeping with
previously reported yeast NMR spectra [31]. Metabolites were
identified on the basis of NMR reference spectra encompassing
more than 700 endogenous compounds. Quantities of metabolites
in each sample were calculated on the basis of integrated peak
areas with respect to the concentration of the internal reference
standard DSS-d6. From the NMR reference spectra, we were able
to identify and accurately quantify 56 yeast endogenous
metabolites excluding ethanol and methanol (see Methods). We
reported the amount of each metabolite as nanomoles per yeast
cell.
The averaged metabolite concentrations for all segregants are
listed in Table S2. Concentrations of a number of amino acids,
including lysine, glycine, and isoleucine, were consistent with
previous measurements of intracellular concentrations [32,33].
The average intracellular concentration of leucine was lower than
previously reported values [32,33], an expected result if synthetic
media were not a fully sufficient source of this amino acid. Such
activity would be consistent with reports of the activity of the
leucine biosynthesis pathway from gene expression [12] and
proteomic [34] measurements of yeast grown under similar
conditions. Arginine, AMP, ADP, and ATP concentrations were
also low relative to previous measurements [32,33], but the
average energy charge was 0.833, and the average NAD/NADH
ratio is 20.022, both within expected normal ranges [35,36].
To assess the variation of metabolite concentrations across
biological replicates of independent yeast cultures, we collected ten
replicate cell extracts for each parental strain at two time points
separated by 2 mo. A comparison between the two parental strains
identified 23 metabolites with significantly different concentrations
(Wilcoxon test p,0.005) (Table S3), indicating that intersample
variation for the different strains was significantly smaller than
interstrain variation for these metabolites.
We next sought to identify genetic loci that were segregating in
the BXR cross with metabolite levels. We used more than 2,000
SNP markers uniformly spaced throughout the yeast genome [11]
to map genetic loci for the 56 reliably scored metabolites. The
peak LOD scores for 16 metabolites (29%) exceeded the genome-
wide significance LOD score threshold of 3.9 (FDR=0.05)
(Table 1). This percentage is similar to the percentage of gene
expression traits that give rise to a similarly significant linkage
signal. Eleven of the 16 metabolite traits with significant metQTLs
(Table 1) were also found to have significantly different
concentrations in the parental strains (Figure 2). We examined
these metQTL results in the context of QTLs controlling gene
expression (eQTL) previously detected in the same BXR cross
[24]. Twelve of the 16 metQTLs were coincident with four
previously identified eQTL hot spot regions to which many more
gene expression traits linked in trans than would be expected by
chance [13,24]. Phenylpyruvate, 2-isopropylmalate, alanine,
arginine, and NAc-glutamate levels were linked to position
100,000 bp on Chromosome III, which was associated with
eQTL hot spot 1; orotic acid and dihydroorotic acid levels were
linked to position 130,000 bp on Chromosome V, which was
associated with eQTL hot spot 2; isoleucine, threonine, and valine
levels were linked to position 70,000 bp on Chromosome XIII,
which was associated with eQTL hot spot 3; trehalose and glycerol
levels were linked to position 180,000 bp on Chromosome XV,
which was associated with eQTL hot spot 4 (Table 1).
Integrating Metabolite and Other -Omics Data to
Construct Networks That Elucidate eQTL Hot Spots
Given the strong genetic signal detected in the metabolite data
and the coincidence of metQTL and eQTL hot spot regions, we
set out to explore an integrated network analysis strategy using the
gene expression profiles [11] as well as the metabolite data
described above. Gene expression and metabolite traits were
treated equivalently as nodes in our BN reconstruction process. As
such, we modified our previously reported BN reconstruction
method [13] to accommodate metabolite data, in addition to
genotype, gene expression, protein interaction, and TF–DNA
binding data. The KEGG biochemical pathway database [37] was
used to generate structure priors between metabolites and genes
Constructing Predictive Regulatory Networks
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in canonical pathways. Intuitively, genes encoding enzymes that
directly catalyze biochemical reactions for the metabolites were
assigned stronger prior probabilities of being related during
network reconstruction, whereas genes that encode enzymes
catalyzing downstream or upstream biochemical reactions of the
metabolites were assigned weaker priors (see Methods for details).
Differentially regulated genes and the structure priors for
genotype, TF–DNA, and protein–protein interaction data were
defined as previously described [13].
The 56 reliably quantified metabolites were included as input
into the BN reconstruction program. From this probabilistic causal
network we can identify subnetworks for all of the metabolites or
any set of genes (see Methods for details). To assess the predictive
power of this network, we examined how metabolites and gene
expression traits relate to one another at the four eQTL hot spots
in Table 1, providing for the possibility of elucidating regulatory
mechanisms and generating testable hypotheses about novel
regulatory relationships.
Subnetwork linked to eQTL hot spot 1. We [13,24] and
others [38] have previously inferred the identity of multiple causal
variants affecting the expression levels of many genes at eQTL hot
spot 1 (the engineered deletion at LEU2 and natural variation at
ILV6). We previously hypothesized that LEU2 affected many gene
expression traits linked to this hot spot by regulating genes that
bind the Leu3p TF. We demonstrated that genes in the LEU2
subnetwork and genes with Leu3p binding sites were
overrepresented among the set of genes making up the LEU2
transcriptional knockout signature [13]. However, despite the
strong statistical and empirical evidence implicating LEU3,w e
found that LEU3 expression levels did not significantly vary in the
BXR cross (Figure S3), suggesting a missing link between the
LEU2 genotype and Leu3p activity resulting in widespread effects
on transcription. In addition to Leu3p concentration and LEU3
gene expression, Leu3p activity is known to be regulated by 2-
isoprolylmalate, an intermediate product in leucine biosynthesis
[39]. By incorporating the metabolite data into the network
reconstruction procedure, we found that levels of 2-
isopropylmalate were strongly linked to the LEU2 locus, and
that LEU2 expression was strongly supported as causal for the
abundance levels of 2-isopropylmalate (Figure 3B). Our integrated
BN indicates that variation in levels of this metabolite are a
consequence of changes in LEU2 expression (Figure 3C and 3D),
and changes in 2-isopropylmalate levels are causal for expression
levels of genes with Leu3p binding sites (Figure 3C and 3D). 2-
isopropylmalate is a key intermediate in the leucine biosynthesis
pathway (Figure 3A), which activates Leu3p and results in
upregulation of its target genes [39]. Therefore, our integrated
view of the data suggests that the metabolite 2-isopropylmalate is
the missing link between LEU2 and Leu3p regulated genes. In fact,
the subnetwork associated with this eQTL hot spot (Figure 3D)
suggests a regulatory mechanism: 2-isopropylmalate mediates the
effect of LEU2 genotype on mRNA expression of Leu3p targets
and metabolites, including alanine, glutathione, phenylpyruvate,
valine, phenylananine, and leucine (Figure 3D). Such regulatory
mechanism is consistent with known regulatory mechanisms of
Leu3p and leucine biosynthesis.
Arginine and N-acetyl-glutamate (NAc-glutamate) are metabo-
lites in the arginine biosynthesis pathway (Figure S4A). Variations
in arginine and NAc-glutamate levels in the BXR cross were also
linked to eQTL hot spot 1 (Figure S4B). The metQTLs for
arginine and NAc-glutamate at this locus were close to genes
encoding arginine biosynthesis enzymes and TFs in our BN
(Figure S4C), consistent with the known role of NAc-glutamate as
Table 1. Metabolite concentrations that are under significant genetic control in the BXR cross (LOD score.3.9 corresponds to FDR
0.05), where the metabolite QTL are coincident with eQTL hot spots.
Metabolite QTL
metQTL eQTL
Chromosome Position LOD Score
n Genes Linked to the
Locus eQTL Hot Spot
Phenylpyruvate III 91287 4.05074 203 1
2-isopropylmalate
a III 91496 15.4214 203 1
Alanine
a III 76127 8.399 203 1
Arginine
a III 91977 5.67128 203 1
NAc-glutamate
a III 91977 5.86485 203 1
Orotic acid
a V 116812 15.4214 41 2
Dihydroorotic acid
a V 117705 4.47374 41 2
SAH
a VIII 167506 13.4212 14 NA
SAM
a VIII 167506 10.3425 14 NA
Isoleucine
a XIII 49894 11.1032 41 3
Threonine
a XIII 49903 10.728 41 3
Valine XIII 46070 4.00333 41 3
Glycerol XV 175594 4.38217 343 4
Lysine
a XV 59733 8.71851 343 4
Trehalose XV 174364 6.03112 343 4
Tyrosine XV 89229 4.48397 343 4
aOf the metabolites listed, 11 are significantly different between the BXR parental strains as well.
doi:10.1371/journal.pbio.1001301.t001
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transcript levels of CPA2, a gene involved in the biosynthesis of
the arginine precursor citrulline, regulate concentrations of
arginine and, further downstream, NAc-glutamate. These results
combined with the inference from our network that ARG4 is a key
node in the eQTL hot spot 1 subnetwork (Figure S4C),
recapitulate the known arginine biosynthesis pathway. Interest-
ingly, we detected a negative correlation between NAc-glutamate
and arginine concentrations across the panel of BXR strains,
suggesting that feedback control points in this pathway lie between
these two metabolites. Our network suggested that sequence
variation in ILV6 was causal for gene expression variation in
GCN4, a master transcriptional regulator of amino acid biosyn-
thesis genes, which in turn is causal for expression variation in TFs
RTG3 and GLN3, and then changes in the arginine biosynthesis
subnetwork more generally in the BXR cross. Such a model is
consistent with the overlaps we observed between the transcrip-
tional profiles of the ILV6 and LEU2 knockouts [13] and this
subnetwork (Fisher exact test p=8:04|10{12 and 9:06|10{15,
respectively). Taken together, our results indicate that the
constructed network in many cases not only recapitulates known
biology in general, but elucidates regulatory mechanisms, such as
networks governing amino acid biosynthesis.
Subnetwork linked to eQTL hot spot 2. The expression
traits linked to this eQTL hot spot include URA3, a gene that is
physically located in this hot spot region. From the BN, URA3 is
predicted as a causal regulator of this eQTL hot spot. A deletion of
URA3 was engineered in the parental strain RM11-1a as a
selectable marker, and segregation of this locus among the BXR
progeny is likely causal for expression variation of uracil
biosynthesis genes linked to this eQTL hot spot [12]. Variation
of two metabolites linked to this locus: dihydroorotic acid, which is
converted to orotic acid by the enzyme Ura1p, and orotic acid
itself, reflects the functional consequence of transcriptional
variation in genes involved in de novo pyrimidine base
biosynthetic processes on metabolite levels. The causal
relationships between URA1, orotic acid, and dihydroorotic acid
as well as the subnetwork for this eQTL hot spot recapitulate the
known pyrimidine base biosynthesis pathway (Figure 4). This
subnetwork not only captures the coregulation of gene expression
Figure 2. Distributions of metabolite concentrations between parental strains and among 120 segregants of a cross between
laboratory (BY) and wild (RM) strains of S. cerevisiae [11]. The y-axis is metabolite concentrations (nanomoles per yeast cell). The genotypes for
segregants are reported at the loci to which the metabolite concentrations were linked. Represented are the metabolites (A) 2-isopropylmalate; (B)
orotic acid; (C) SAH; and (D) threonine.
doi:10.1371/journal.pbio.1001301.g002
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how genetic variation in URA3 affects orotic acid and
dihydroorotic acid levels.
Subnetwork linked to eQTL hot spot 3. Variations in the
levels of isoleucine, threonine, and valine were linked to eQTL hot
spot 3, along with the subnetwork in which these three metabolites
reside. Little is known about the biological processes associated with
this locus [13,24]. However, we noted surprisingly that while the
expression levels of six of seven genes in the isoleucine biosynthesis
pathway were linked to eQTL hot spot 1 on Chromosome III, the
concentrations of isoleucine and threonine linked to eQTL hot spot
3 (Table 1 and Figure 5a). We had previously shown that genes
whose transcript levels linked to eQTL hot spot 1 on Chromosome
III were enriched for amino acid biosynthesis pathways [13], with
five amino acid and intermediate metabolites also linked to this
locus (Table 1). These linked biomolecules included several
regulators of branched-chain amino acid biosynthesis and the
amino acids themselves. Interestingly, valine concentrations linked
both to eQTL hot spots 1 and 3 (Figure 6A) along with valine
associated metabolites (Figure 6B), suggesting that both loci may
ultimately prove to be key regulators for a majority of amino acid
levels in the BXR cross.
Two subnetworks were associated with eQTL hot spot 3
(Figure 5B). In the larger subnetwork, the metabolites isoleucine,
valine, and threonine were inferred to connect through threonine
to the expression levels of CHA1 (Figure 5B), consistent with the
known function of Cha1p as a catabolic serine/threonine
deaminase, which is transcriptionally regulated by serine and
threonine [40]. Expression levels of other amino acid catabolism
genes (BAT2, ILV5, and GCV1-3) were also placed in this
subnetwork, and the set of genes comprising this subnetwork
was enriched for genes in the gene ontology (GO) Biological
Process category ‘‘nitrogen compound metabolism’’ (Fisher exact
test p=3:54|10{6). By contrast, the smaller subnetwork was
enriched for genes in the GO Biological Process de novo inosine
monophosphate (IMP) biosynthetic process category (Fisher exact
test p=7:77|10{14
). The known relationship between amino
acid and purine nucleotide biosynthesis [41,42] suggests a model
in which a master regulator at eQTL hot spot 3 controls
expression of both subnetworks of genes and metabolites.
Given that our network approach did not predict a causal
regulator for eQTL hot spot 3, we examined whether cis-
regulatory sequence variations in the BXR cross affected the
expression of a gene located in this region and then whether such a
Figure 3. Relationship between 2-isoproplymalate and genes linked to eQTL hot spot 1 on Chromosome III. (A) 2-isopropylmalate is an
intermediate metabolite in the leucine biosynthesis pathway and LEU2 is a key enzyme in this pathway; (B) 2-isopropylmalate concentrations are
linked to the LEU2 locus and is reactive to LEU2 expression; (C) 2-isopropylmalate is reactive to LEU2 and causal for genes with Leu3p binding sites
(red nodes); (D) a zoomed-in view of the subnetwork highlighted in (C) (around 2-isopropylmalate). Hexagon-shaped nodes represent metabolites,
circular nodes represent genes, and diamond-shaped nodes represent genes with cis-eQTLs.
doi:10.1371/journal.pbio.1001301.g003
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this locus. TAF13 was the only gene located in the eQTL hot spot
3 locus with cis-regulatory expression variation, but this gene was
not connected to any of the inferred subnetworks associated with
this hot spot.
Reasoning that TAF13 was unlikely to be the causal regulator of
the eQTL hot spot, we hypothesized instead that the underlying
causal variant might lead directly to a protein activity change
rather than to a change in transcript levels. To identify such
protein-coding variants, we compared the genomes of BY and RM
at this locus and found nonsynonymous changes in YML096W,
VPS9, ARG81, TSL1, CAC2, and NUP188. We considered each of
these genes as a candidate regulator for the eQTL hot spot 3 locus.
To evaluate these candidates, we anticipated that for any true
causal gene at the locus, the protein product of the gene would be
necessary for maintaining wild-type metabolite levels in a single
tester strain. As such, we experimentally tested knockout strains for
each candidate gene in the BY background, comparing in each
case the concentrations of metabolites with those of the wild type.
The results, listed in Table S4 and Figure S5, revealed dramatic
changes in metabolite levels for the knockout of the vacuolar
transport regulator VPS9, compared to the other candidate genes,
where the corresponding knockouts had modest to insignificant
metabolite changes. Loss of VPS9 was associated with changes in
threonine, isoleucine, valine, and serine concentrations, something
we would expect if VPS9 was the causal regulator for this linkage
hot spot, given amino acids linked to this hot spot reside in the
corresponding subnetwork (Figure 6C). The VPS9 deletion also
affected ADP and ATP concentrations, consistent with the de
novo IMP and purine nucleotide biosynthetic process associated
with this locus, as discussed above. Many metabolites are
interconnected in the network (Figure 6B) so that VPS9 deletion
has a broad effect on metabolite concentrations (Figure 6C).
We further profiled the effects the VPS9 deletion had on the
expression levels of the 16 genes in the small eQTL hot spot 3
subnetwork. We observed significant expression changes in the
knockout relative to wild-type in eight of the 16 genes tested
(p,2:2|10{16) (Figure 5C; Tables S5 and S6), including those
genes annotated in amino acid catabolism and nucleotide
biosynthesis. Taken together, our results implicate VPS9 as a
major determinant of amino acid levels and expression of amino
acid catabolism genes, with strong experimental support for
sequence variation in VPS9 serving as the causal factor underlying
the changes in these biomolecules in the BXR cross.
Figure 4. Relationship between metabolites and genes linked to eQTL hot spot 2 on Chromosome V. (A) De novo biosynthesis of
pyrimidine pathway; (B) orotic acid and dihydroorotic acid concentrations are linked to the URA3 locus; (C) URA3 is predicted as the causal regulator
for genes and metabolites linked to the eQTL hot spot. Red nodes are genes or metabolites whose variations are linked the Chromosome V locus. The
shapes of the nodes follow the convention described in Figure 3.
doi:10.1371/journal.pbio.1001301.g004
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has been identified by us and others as a major driver of expression
differences in the BXR cross for genes involved in stress response
[13,24]. Previous work has investigated the role of sequence
variation in IRA2 [23] and PHM7 [13] as causal regulators at this
locus. Interestingly, though the levels of hundreds of transcripts
coinherited with sequence variants at the Chromosome XV eQTL
hot spot locus, the levels of proteins encoded by such transcripts
did not generally show linkage to the locus [34], leading to
speculation that the mRNA variation may not have appreciable
downstream consequences. In our metabolite data, abundances of
trehalose and glycerol, both implicated in the yeast stress response
[43], were significantly linked to this locus (Figure 7A and 7B).
Our network predicted HOR2 expression as a determinant of
glycerol levels, consistent with the known function of Hor2p in
glycerol synthesis and its regulation by the stress response TF
complex Msn2/4. In our network the metabolite trehalose was
located in a subnetwork with TPS2, TPS1, and TSL1 (Figure 7C),
consistent with the known function of these genes as trehalose
synthase components. MSN2 was predicted by the network as an
upstream regulator of trehalose synthesis (where MSN2 activity
was represented by CTT1 in the network), recapitulating the
known stress response function of Msn2p. Further upstream of this
process, our network predicted PHM7 as the major causal
regulator of the entire subnetwork. Little is known about the
function of Phm7p, but in support of a causal role for variation at
this gene in control of stress response, we previously showed that a
knockout of PHM7 affects expression of many genes with linkage
to the Chromosome XV eQTL hot spot 4 locus [13].
To validate our prediction that PHM7 affects the abundance of
stress response metabolites such as trehalose and glycerol in
addition to stress response genes linked to the eQTL hot spot, we
profiled metabolite levels in the PHM7 knockout and wild-type
strains (Methods). The abundance of trehalose in the PHM7
knockout strain was 2.46higher compared to the wild-type strain
(p=0.03), which was the largest fold change among all
metabolites. However, the abundance of glycerol in the PHM7
knockout strain did not significantly change. PHM7 has a stronger
effect on trehalose abundance than on glycerol abundance, which
is consistent with the metQTL results that the metQTL LOD
score of trehalose at the eQTL hot spot 4 locus is 6.03, while the
metQTL LOD score of glycerol is 4.38.
Figure 5. Genes and metabolites linked to eQTL hot spot 3 on Chromosome XIII. (A) Variations of the metabolites isoleucine and threonine
are linked to this locus. (B) These two subnetworks comprise genes and metabolites enriched for linking to the Chromosome XIII locus. The larger
network consists of both gene expression and metabolite nodes enriched for the GO biological process nitrogen compound metabolism. The smaller
network is enriched for the GO biological process de novo IMP biosynthetic process. Red nodes are genes with eQTLs linked to the Chromosome 13
locus. (C) Expression levels of eight genes (in red) are different between VPS9 knockout and the wild-type strains. The shapes of the nodes follow the
convention described in Figure 3.
doi:10.1371/journal.pbio.1001301.g005
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metabolites whose abundance levels were significantly different
(p,0.05) between the knockout and wild-type strains (Table S7),
including phosphoenolpyruvate (a key intermediate metabolite in
glucolysis and gluconeogenesis) and a number of amino acids and
their intermediates. These metabolites are closely associated with
the metabolites whose abundance levels are linked to eQTL hot
spots 1 and 3 (Figure 8A). Using a Bayesian partition method, we
previously predicted a module of 83 genes including ILV6 is
modulated by eQTL hot spots 1, 3, and 4 on Chromosomes III,
XIII, and XV, respectively, with eQTL hot spot 1 also enriched
for genes involved in amino acid metabolism [44]. Genes whose
expression levels are linked to both eQTL hot spots 1 and 4,
including HIS7, YMC2, and HCM1, are colocalized to the same
subnetwork associated with eQTL hot spot 4 (Figure 8B). HIS7, an
enzyme involved in histidine, purine, and pyramidine biosynthesis,
is linked to the rest of the subnetwork through the amino acid
biosynthesis regulator GCN4 (Figure 8C). That the PHM7
knockout metabolite signature contains amino acids and their
intermediate metabolites linked to eQTL hot spots 1, 3, and 4
(Figure 8A), not only confirms the biological consequence of
transcriptional changes and validates our prediction of the
biological function of the eQTL hot spot 4 subnetwork, but it
also validates our predictions of interconnectivity of eQTL hot
spots 1, 3 and 4 [8].
Given the known cis-acting regulatory changes between BY and
RM at the PHM7 gene [45], together with the gene expression and
metabolite profiles of the PHM7 knockout and wild-type strains,
one interpretation of our identification of PHM7 as the causal
regulator of this stress response network is that its expression
variation creates a stress condition that activates Msn2/4, which in
turn activates stress response genes. Our network suggests
regulatory relationships among stress response genes and metab-
olites, and enables emergent hypotheses about novel genes in the
stress response pathway.
Discussion
By integrating six different fundamental types of data, including
RNA expression, DNA variation, DNA–protein binding, protein–
metabolite interaction, and protein–protein interaction data, with
metabolite data, we constructed a BN using an approach that
Figure 6. Metabolite subnetwork. (A) Variations in valine concentrations are linked to two eQTL hot spots; Chromosome III:100,000 and
Chromosome XIII:70,000. (B) Most metabolites are connected. Valine connects to metabolites linked to eQTL hot spots at Chromosome III:100,000
(nodes in blue) and Chromosome XIII:70,000 (nodes in green). (C) 25 metabolites (in red) whose concentrations are different between VPS9 knockout
and the wild-type strains are in this subnetwork. This structure suggests that VPS9 is causal for the variations of these metabolites. The shapes of the
nodes follow the convention described in Figure 3.
doi:10.1371/journal.pbio.1001301.g006
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network providing a number of novel insights into the mechanisms
of the eQTL hot spots in a segregating yeast population (the BXR
cross). Importantly, we validated the biological consequences of
the transcriptional variation linked to each of the four eQTL hot
spots identified in the BXR cross to which metabolite levels were
also linked. Our results indicate that the incorporation of
metabolite levels into the network reconstruction process signifi-
cantly enhanced the utility of the network-based models [46,47].
While the integration of metabolite abundance and gene
expression traits in a genetic context have been attempted in
plants [48] and mouse [49], the main distinguishing characteristic
of our study is the de novo construction of a global molecular
network that simultaneously incorporates many different types of
information (DNA, RNA, protein, and metabolite), along with
known biochemical pathways as prior information. To aid in
further understanding how we integrate these data to construct
probabilistic causal networks, and to enhance the ability to repeat
our results, we provide as Text S1 results of an in-depth
description of the construction of the URA3 subnetwork
(Figure 4), using different types of data to assess the contributions
of different data types to the predictive power of the network and
to the identification of key modulators of important biological
processes. We examined in detail all 4 eQTL hot spots that
coincided with metQTLs. Our findings for eQTL hot spots 1 and
2 recapitulated well-known biological processes, and for eQTL hot
spots 3 and 4 our predictions implicated novel genes as modulators
of established biological processes, which we subsequently
validated prospectively. Among the many predictions made by
our network, we uncovered novel insights into the biological
processes that in the BXR cross are responsible for variations in
amino acid levels. While amino acid concentrations are known to
be regulated by multiple processes (e.g., synthesis, degradation,
recycle, and storage), our approach objectively identified that
variations in concentrations of a number of amino acids in the
BXR cross were affected by both the amino acid biosynthesis and
degradation pathways. We predicted and prospectively validated
VPS9 as a major driver of amino acid concentrations via the amino
acid degradation pathway. These results open novel and
interesting questions about the mechanism by which sequence
Figure 7. Genes and metabolites linked to eQTL hot spot 4 on Chromosome XV. (A) Variations in the metabolites glycerol and (B) trehalose
are linked to this eQTL hot spot. (C) The part of the subnetwork associated with this eQTL hot spot consists of the causal regulator PHM7 at the top,
key TFs MSN4 and MSN2 (represented by CTT1), and the genes that encode for the trehalose synthesase complex. Red nodes are genes or
metabolites with QTL linked to the Chromosome XV locus.
doi:10.1371/journal.pbio.1001301.g007
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vesicle-mediated vacuolar protein transport, and in Saccharomyces
cerevisiae, the vacuole is the main compartment for amino acid
storage, recycling, and cytosolic amino acid concentration
maintenance [50]. The cellular effects of variation in VPS9 are
likely mediated by differential regulation of amino acid storage in
the vacuole; we speculate that such storage changes may affect
cytosolic amino acid pools that in turn have downstream
consequences on transcript and protein levels of amino acid
pathways, as has been shown for CHA1 [40] and GCV3 [51].
However, only with enhanced screening of all molecular states of
the systems can we achieve a complete understanding of these
processes. Thus, while the integrated BN elucidated some of the
mechanistic underpinnings of the eQTL hot spots in the BXR
cross, additional information will be required to more fully
understand how processes perturbed in the BXR cross lead to
phenotypic changes.
Despite lacking an exhaustive assessment of all molecular traits
in the BXR cross, it is of particular note that the strong
correlations we observed between gene expression and metabolite
data may help resolve an ongoing debate regarding the functional
consequences of gene expression regulation. While some reports
indicate that gene expression levels and protein abundances are
not well correlated [52], other reports indicate a high degree of
correlation [53]. A recent proteomic study in the BXR cross
demonstrated that a large number of protein levels are linked to
eQTL hot spots [34], two of which (the eQTL hot spots 1 and 3)
were highlighted in our present work. Metabolites are the final
functional products of protein activity regulation. We showed that
PHM7 not only alters expression levels of stress response genes
linked to eQTL hot spot 4, but also alters the abundance of
trehalose, a metabolite product of the stress response genes. Our
results demonstrate that gene expression and metabolite levels are
not only strongly correlated, but that a significant proportion of
that covariation can be explained by common genetic control.
Given that variations in protein levels can result from sequence-
specific transcriptional and translational regulation or from
nonsequence-specific protein degradation, the integration of gene
expression and metabolic traits can help dissect the complex
processes that regulate protein levels.
The yeast growth conditions for metabolite profiling were the
same as previously used to generate the gene expression data in the
BXR cross [12]. Both gene expression and metabolite abundances
are under strong genetic regulation and are linked to common
eQTL hot spots (Table 1). When metabolite data were integrated
with gene expression data, our resulting integrated network was
able to recapitulate the mechanism of multiple known biological
processes that in turn explained the connection between genes
linked to the LEU2 locus and genes with Leu3 binding sites, with
the metabolite 2-isopropylmalate objectively identified as the key
intermediate. These results also confirmed that changes in
expression of stress response genes lead to changes in stress
response metabolites such as trehalose. Therefore, the integration
of the gene expression and metabolite data has provided new
insight into common biological processes that are perturbed by
genetic variation segregating in the BXR cross.
Going forward, as more technologies emerge that can generate
large-scale data in different dimensions for low cost, we will
achieve a more complete understanding of biological systems only
if we integrate all of the information together to consider all of the
different cellular components and how they interact with one
another at the population level. For example, comprehensive
proteomic data and protein phosphorylation data are needed and
should be further integrated with other high throughput genomic
and genetic data. For metabolites, their cellular abundances are
not only affected by specific enzymes in related biochemical
reactions, but they are also affected by proteins that bind them or
transport them into different cellular compartments. Further
research on how to integrate these data into networks is needed. In
addition, there is an abundance of existing knowledge, such as
genetic interactions and regulatory cascades, which can be
converted into prior information and integrated with other data
and priors. Further efforts in developing methods to integrate these
diverse data and information are warranted. In more complex
systems, we will need to consider the fundamental building blocks
of a cell in the context of cell–cell interactions that lead to tissue-
based networks, the interactions of tissues that lead to organ-based
networks, and the interactions of organs in a given system to
understand the physiological states of that system associated with
complex phenotypes of interest, given these phenotypes emerge
from this complex web of interacting networks [54]. Only by
taking the full complement of raw data available on living systems
can we move from the accumulation of knowledge to actual
understanding, and from understanding, wisdom.
Methods
Strains in the Yeast BXR Cross and Growth Conditions
Yeast parental strains BY4716 (MATa lys2D0) and RM11-1a
(MATa leu2D0 ura3D0 HO:kan) and 111 segregants of BXR cross
[11] were provided by R. Brem. Auxotrophies, mating type, and
G418 resistance were confirmed for all strains to be as previously
reported [12]. Cells were grown under identical conditions as
previously described [12]. Strains were freshly started from freezer
stocks and stored at room temperature on synthetic complete
medium plates for no longer than 1 wk before each experimental
run. For each run, cells from the plates were precultured in 10 ml
of synthetic complete media (Table S8) at 30uC with shaking for
24 h. These cultures were then diluted into 25 ml fresh synthetic
complete media to an optical density of 0.005 to 0.02. This starting
density was determined from previous growth rate measurements
and empirical observations such that after overnight growth at
30uC, the cultures would be exponentially growing, i.e., at a cell
density of less than 2610
7 cells/ml. Overnight cultures were
diluted into 52 ml fresh synthetic complete medium to an optical
density of 0.1, and incubated with shaking for approximately 5 h
at 30uC. Starting at 3 h after dilution, optical density was
monitored every 60 min. Cell suspensions were counted in a
hemocytometer to obtain cell count per OD values and an
Figure 8. The PHM7 knockout metabolite signature suggests interconnectivity of multiple eQTL hot spots. (A) The metabolite
subnetwork is the same as the subnetwork depicted in Figure 6A. 27 metabolites (in red) whose concentrations differ between the PHM7 knockout
and the wild-type strains are in this subnetwork. In addition to trehalose, which is linked to the eQTL hot spot 4, the PHM7 knockout metabolite
signature includes metabolites whose concentrations are linked to eQTL hot spots 1 and 3 (on Chromosomes III and XIII, respectively), suggesting
interactions among eQTL hot spots 1, 3 and 4, as we have previously predicted [44]. (B) The subnetworks for eQTL hot spot 4 (extracted using genes
linked to eQTL hot spot 4) suggests that part of this network is regulated by both eQTL hot spots 2 and 4. Red nodes are genes whose expression
values are linked to eQTL hot spot 2. (C) A zoomed-in view of the part of the network regulated by eQTL hot spots 2 and 4. The gene that links this
part of the network to the rest of the subnetwork associated with eQTL hot spot 4 is GCN4, a master TF regulating amino acid biosynthesis.
doi:10.1371/journal.pbio.1001301.g008
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produced flocculent cultures under these growth conditions, all
cultures were diluted 56 into 0.25 ml PBS and sonicated three
times on ice for 45 s using a Misonix sonicator 3000 equipped with
a microprobe before optical density was determined and/or cells
were counted. At an optical density of approximately 1.0, each
exponentially growing culture was concentrated 10-fold by rapid
centrifugation at room temperature and suspension of the cells in
5 ml of synthetic complete medium prewarmed to 30uC. These
concentrated cell suspensions were then incubated at 30uC with
shaking for 1 h. Metabolites were then immediately extracted
from the cells in these concentrated suspensions.
Yeast Knockout Strains and Growth Conditions
Yeast parental strain BY4742 (MATa his3D1 leu2D0 met15D0
ura3D0) and six deletion strains derived from it (Dtsl1::kanMX,
Dnup188::kanMX, Dcac2::kanMX, Dyml096w::kanMX, Dvps9::kanMX,
and Darg81::kanMX) were provided by Elton Young’s lab,
Department of Biochemistry, University of Washington, from a
copy of the Yeast Deletion Consortium knockout collection
prepared in Stanley Fields’ lab, Department of Genome Sciences,
University of Washington. Cells were grown under identical
conditions as the BXR cross strains in synthetic complete medium,
and metabolite extracts were also obtained and further processed
in identical fashion (see below). Each experiment was repeated on
three different days.
Yeast parental strain BY4743 (MATa/MATa his3D1/his3D1
leu2D0/leu2D0 lys2D0/+ met15D0/+ ura3D0/ura30) was ob-
tained from ATCC (Manassas, Virginia), and the derived PHM7
knockout strain 31775 (phm7::KanMX/phm7::KanMX) con-
structed by the Yeast Deletion Project [55] was obtained from
Open Biosystems (Huntsville, Alabama). Cells were grown under
identical condition as the PHM7 knockout gene expression
experiment [13], and metabolites were extracted as described
below. Each experiment was repeated on three different days.
Quantitative PCR
BY4742 and Dvps9 strains (both MATa) were grown as
described above and harvested by centrifugation in crushed ice
when cells reached optical density of approximately 1.0. Total
RNA was extracted using RNeasy mini-columns, transcribed with
SMARTScribe Reverse Transcriptase (Clontech) from oligo(dT),
and diluted 1,0006. Real-time PCR was run for 17 genes
(including VPS9) associated with the Chromosome XIII eQTL hot
spot subnetworks and ACT1 internal standard gene (Table S6) on
an ABI 7900HT instrument with 26 Sensimix dT (Quantance),
primers at 0.2 mmol/l, and SYBR Green reagent. Relative
expression was calculated using the DDCt method with ACT1
internal standards [56]. TAF9 was used to estimate the false
positive rate as 0.033.
Metabolite Extraction
Intracellular metabolites were extracted using a modification of
previously described methods [31,57]. First, all intracellular
metabolic processes were rapidly quenched by pipetting each
concentrated cell suspension into 20 ml of rapidly mixing 60% (v/
v) methanol at 240uC. Cells were rapidly (5 min) sedimented in a
centrifuge precooled to 28uC and washed twice with 20 ml of the
240uC methanol. Metabolites were then extracted with boiling
75% (v/v) ethanol at 80uC and 0.25 ml dry volume of acid-washed
glass beads (Sigma G1277), by vigorous vortexing for 30 s. The
cell-glass bead slurry was incubated 3 min at 80uC, vortexed 30 s,
and then placed on ice for 5 min. Large cellular debris and glass
beads were removed by centrifugation at 2,000 g for 5 min. The
resulting ethanolic extracts were clarified by three rounds of
centrifugation at 14,000 g in a microcentrifuge. The clarified
metabolite extracts were stored at 280uC until drying. Extracts
were dried in a Savant Speed Vac under 150 mtorr vacuum in low
retention microcentrifuge tubes. Dried metabolite extracts were
stored at 280uC until preparation for NMR analysis.
NMR Spectrum Acquisition and Metabolite Identification
and Quantification
The process of NMR spectra acquisition and quantification
follows the previously outlined procedure [29]. Dry metabolite
extracts were dissolved in 0.7 ml deuterated 80 mM potassium
phosphate buffer (containing 2 mM DSS-d6 as an internal
reference standard), and transferred to 100-mm 5-ml NMR tubes.
NMR samples were stored in Varian 768AS auto-sampler at 8uC
before and after NMR analyses. NMR data were acquired on the
Varian 700 MHz NMR spectrometer at 25uC with one-dimen-
sional proton pulse sequence. The water peak was suppressed by
the WET pulse sequences [58]. For each sample, 512 acquisitions
were acquired with 3 s of acquisition and 15 s of delay between
pulses.
Analyses of NMR spectra were carried out using DataChord
Spectrum Miner (One Moon Scientific, Inc.). Stacked NMR
spectra were referenced to DSS-d6 as 0 ppm, and peaks of each
endogenous metabolite were checked against their reference
spectra (about 700 common endogenous metabolites). Each
metabolite usually displays multiple peaks, for example trehalose,
shown in Figure S6. Overlapping peaks were quantified by peak
area correction according to stoichiometric peak ratios for each
metabolite.
Genetic Variations as Anchors of Causal/Reactive
Relationships in F2 Crosses
For three correlated variables T1, T2, andL, there are three









For example, the three graphs in the group G1,
L?T1?T2,L/T1?T2,L/T1/T2, describe the same set of
condition independent relationship that L and T2 are independent
conditioning on T1. The three graphsL?T1?T2,L/T1?T2,
L/T1/T2 have the same probabilities and are called Markov
equivalent. In an F2 cross, we can represent quantitative traits as
T1 and T2, and the genetic locus as L. In an F2 cross experimental
design, all F2 strains are under the same experimental condition.
Therefore, the only source of variation in the quantitative traits T1
and T2 are genetic differences in L, so that the relationships
L?T1 and L?T2 are plausible. On the other hand, the genetic
variation in L is stable and does not change during an F2 cross
experiment, so that L/T1 and L/T2 are not plausible. Thus in
an F2 cross, only one graph in each of the three Markov
equivalent groups above is plausible. We can simplify the above
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relationship in a F2 cross.
Inferring Causal Relationships between Quantitative
Traits
For two quantitative traits T1 and T2 linked to the same locus L
in the yeast cross, there are three basic relationships that are
possible between the two traits relative to the DNA locus L as
described above. Either DNA variations at the locus L lead to
changes in trait T1 that in turn lead to changes in trait T2,o r
variations at locus L lead to changes in trait T2 that in turn lead to
changes in trait T1, or variations at locus L independently lead to
changes in traits T1 and T2, as previously described [14].
Assuming standard Markov properties for these basic relation-
ships, the joint probability distributions corresponding to these
three models, respectively, are:
1. PL ,T1,T2 ðÞ ~PL ðÞ PT 1DL ðÞ PT 2DT1 ðÞ
2. PL ,T1,T2 ðÞ ~PL ðÞ PT 2DL ðÞ PT 1DT2 ðÞ
3. PL ,T1,T2 ðÞ ~PL ðÞ PT 2DL ðÞ PT 1DT2,L ðÞ ,
where the final term on the right-hand side of equation M3 reflects
that the correlation between T1 and T2 may be explained by other
shared loci or common environmental influences, in addition to
locus L. We assume Markov equivalence between T1 and T2 for
model M3 so that PT 2DL ðÞ PT 1DT2,L ðÞ ~PT 1DL ðÞ PT 2DT1,L ðÞ .
PL ðÞ is the genotype probability distribution for locus L and is
based on a previously described recombination model [59]. The
random variables T1 and T2 are taken to be normally distributed
about each genotypic mean at the common locus L, so that the
likelihoods corresponding to each of the joint probability
distributions are then based on the normal probability density
function, with mean and variance for each component given by:
(1) for PT 1DL ðÞ the mean and variance are ET 1DL ðÞ ~mT1L and
Var T1DL ðÞ ~s2
T1, (2) for PT 2DL ðÞ the mean and variance are
ET 2DL ðÞ ~mT2L and Var T2DL ðÞ ~s2
T2, and (3) for PT 1DT2 ðÞ the






Var T1DT2 ðÞ ~ 1{r2   
s2
T1, where r represents the correlation
between T1 and T2, and mT1L and mT2L are the genotypic specific
means for T1 and T2, respectively. The mean and variance for
PT 2DT1 ðÞ follow similarly from that given for PT 1DT2 ðÞ . From
these component pieces, the likelihoods for each model are formed
by multiplying the densities for each of the component pieces
across all of the individuals in the population [14]. The likelihoods
are then compared among the different models in order to infer
the most likely of the three. Because the number of model
parameters among the models differs, a penalized function of the
likelihood was used to avoid the bias against parsimony. The
model with the smallest value of the penalized statistic
{2log Li(^ h hiDL,R,C)zk|pi
was chosen. Here, Li(^ h hiDL,R,C) is the maximum likelihood for the
ith model, pi is the number of parameters in the ith model, and k is
a constant. In this instance we took the penalized statistic to be the
Bayesian Information Criteria (BIC) where k is set to log n ðÞ , with n
denoting the number of observations.
Reconstructing Bayesian Network
BNs are directed acyclic graphs in which the edges of the graph
are defined by conditional probabilities that characterize the
distribution of states of each node given the state of its parents
[60]. The network topology defines a partitioned joint probability
distribution over all nodes in a network, such that the probability
distribution of states of a node depends only on the states of its
parent nodes: formally, a joint probability distribution p(X) on a
set of nodes X can be decomposed as p(X)~P
i
p(XiDPa(Xi)),
where Pa(Xi) represents the parent set of Xi. In our networks,
each node represents a quantitative trait that can be a gene or a
metabolite. These conditional probabilities reflect not only
relationships between genes, but also the stochastic nature of
these relationships, as well as noise in the data used to reconstruct
the network.
Bayes formula allows us to determine the likelihood of a
network model M given observed data D as a function of our prior
belief that the model is correct and the probability of the observed
data given the model: P(MDD)~P(DDM)   P(M). The number of
possible network structures grows super-exponentially with the
number of nodes, so an exhaustive search of all possible structures
to find the one best supported by the data is not feasible, even for a
relatively small number of nodes. We employed Monte Carlo
Markov Chain (MCMC) [61] simulation to identify potentially
thousands of different plausible networks, which are then
combined to obtain a consensus network (see below). Each
reconstruction begins with a null network. Small random changes
are then made to the network by flipping, adding, or deleting
individual edges, ultimately accepting those changes that lead to
an overall improvement in the fit of the network to the data. We
assess whether a change improves the network model using the
BIC [62], which avoids overfitting by imposing a cost on the
addition of new parameters. This is equivalent to imposing a lower
prior probability P(M) on models with larger numbers of
parameters.
Even though edges in BNs are directed, we can’t in general
infer causal relationships from the structure directly. For
example, in a network with two nodes, X1 and X2, the two
models X1?X2 and X2?X1 have equal probability distributions
as p(X1,X2)~p(X2DX1)p(X1)~p(X1DX2)p(X2). Thus, with corre-
lation data itself, we can’t infer whether X1 is causal for X2 or vise
versa. In the more general case, for a network with three nodes,
X1, X2, and X3, there are multiple groups of structures that are
mathematically equivalent. For example, the following three
different models, M1 : X1?X2,X2?X3, M2 : X2?X1,X2?X3,
and M3 : X2?
X1,X3?X2, are Markov equivalent (which means that they all
encode for the same conditional independent relationships). In
the above case, all three structures encode the same conditional
independent relationship, X1\ = X3DX2, X1 and X3 are indepen-




Thus, we can’t infer whether X1 is causal for X2 or visa-versa
from these types of structures. However, there is a class of
structures, V-shape structures (e.g., Mv : X1?X2,X3?X2),
which have no Markov equivalent structure. In this case, we
can infer causal relationships. There are more parameters to
estimate in the Mv model than M1, M2, or M3, which means a
large penalty in the BIC score for the Mv model. In practice, a
large sample size is needed to differentiate the Mv model from
the M1, M2, or M3 models.
Incorporating genetic data as a structure prior in the BN
reconstruction process. In general, BNs can only be solved to
Markov equivalent structures, so that it is often not possible to
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through BNs are directed graphs. However, the BN reconstruction
algorithm can take advantage of the experimental cross design (or
segregating populations more generally) by incorporating genetic
data to break the symmetry among nodes in the network that lead
to Markov equivalent structures, thereby providing a way to infer
causal directions in the network in an unambiguous fashion [63].
We modified the reconstruction algorithm to incorporate genetic
data as prior evidence that two quantitative traits may be causally
related based on previously described causality test [63]. The
genetic priors are constructed from three basic sources: (1) genes
with cis-eQTLs [64] are allowed to be parent nodes of genes with
coincident trans-eQTLs, p(cis{wtrans)~1, but genes with
trans-eQTLs are not allowed to be parents of genes with cis-
eQTLs, p(trans{wcis)~0. (2) The eQTL analysis described
above was carried out to identify suggestive eQTLs for all
expression traits [65] (LOD scores greater than 2.8, corresponding
to less than 1 QTL expected by random across genome). Genes
from this analysis with cis- or trans-eQTL were then tested
individually for pleiotropic effects at each of their eQTL to
determine whether any other genes in the set were driven by the
same eQTL [59,66]. If such pleiotropic effects were detected, the
corresponding gene pair and locus giving rise to the pleiotropic
effect were used to infer a causal/reactive or independent
relationship based on a formal causality test [14]. The
reliabilities of the inferred relationship between genes A and B
at a given locus li, p(A{wBDA,B,li), p(B{wADA,B,li), and
p(A\BDA,B,li), were then estimated by a standard bootstrapping
procedure [67]. If an independent relationship is inferred
(p(A\BDA,B,li)w0:5), then the prior probability that gene A is






, where the sums are taken over all loci used
to infer the relationship. If a causal or reactive relationship is
inferred (p(A{wBDA,B,li) or p(B{wADA,B,li) is greater than








. (3) If the causal/
reactive relationship between genes A and B could not be
determined by sources (1) or (2), then the complexity of the eQTL
signature for each gene was taken into consideration. Genes with a
simpler, albeit stronger eQTL signature (i.e., a small number of
eQTLs that explains the genetic variance component for the gene,
with a significant proportion of the overall variance explained by
the genetic effects) were taken to be more likely to be causal
compared to genes with more complex and possibly weaker eQTL
signatures (i.e., a larger number of eQTLs explaining the genetic
variance component for the gene, with less of the overall
variance explained by the genetic effects). The structure prior




, where n(A) and n(B) are the
number of eQTLs with LOD scores greater than 2.8 for A and B,
respectively. We have found that both information on cis-acting
eQTLs (excluding edges into certain nodes) and information on
trans-acting eQTLs (increasing the likelihood of some edges over
others) improve the quality of the network reconstruction [68]. We
note that in applying this particular version of the BN
reconstruction algorithm (incorporating genetic information as a
prior), if genetic information is not available or is ignored, the
population is simply treated as a population with random genetic
perturbations.
Incorporating TFBS and PPI data as network priors in the
BN reconstruction process. Just as genetic data can be
incorporated as a network prior in the BN reconstruction
algorithm, we can similarly incorporate TFBS and protein
complex data to establish prior evidence of a causal relationship
between any gene pair. The PPI data were used to infer protein
complexes to enhance the set of manually curated protein complex
data [69]. Protein complexes were identified from the PPI data
using the clique community analysis described above. The PPI-
inferred protein complexes were then combined with the manually
curated set, and each protein complex in this combined set was
examined for common TF binding sites. If at least half of the genes
in a protein complex carried a given TFBS, then all genes in the
complex were included in the TFBS gene set as being under the
control of the corresponding TF.
There are 119 TFs in the TFBS prediction set considered for
this study [70], and 75 of these were included in the network
because they met the criteria defined above for a gene to be
included in the network (the others did not meet these criteria).
Because TF activity can be regulated at the protein level (e.g., by
phosphorylation), absence of detectable differential expression
does not necessarily imply TF activity is not being actively
regulated. Therefore, to account for the impact the 44 TFs that
did not meet the criteria for inclusion in the network, may have on
the expression of other genes, instead of introducing latent
variables to represent activity of these TFs, we selected a gene
from the set of genes predicted to respond to each of these TFs to
represent the activity of the TF in the following way: (1) select the
top five genes within the TF’s responding gene set that were
included in the network and that were supported as causal for the
most genes in the set; and (2) select the gene with the highest LOD
score at the common locus shared by the top five genes to
represent the QTL signature of the TF. This same procedure was
carried out for those protein complexes that were included in the
TFBS set, as described above.
Given that the scale-free property is a general property of
biological networks as shown in the main text and by others [71],
we incorporated the enhanced TFBS set into the network
reconstruction process by constructing scale-free priors, in a
manner similar to the scale-free priors others have constructed to
integrate expression and genetic data [72]. Given a TF T, and a
set of genes, G, that contain the binding site of T, we define the TF
prior, ptf, so that it is proportional to the number of expression











. The correlation cutoff rcutoff was
determined by permuting the data and then selecting the
maximum correlation values in the permuted datasets (corre-
sponding to a FDRv1:5|10{5). This form of the structure prior
favors TFs that have a large number of correlated responding
genes.
From this set of priors computed from the extended TFBS set,
only non-negative priors were used to reconstruct the BN. This
resulted in scale-free priors from 18 TFs and five protein
complexes being incorporated in the network reconstruction
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protein complexes incorporated into the network reconstruction
process were all large, with one representing the spliceosome and
the other four representing the cytoplasmic and mitochondria
ribosomes. For those protein complexes that could not be
integrated into the network reconstruction process using scale-free
priors, uniform priors were used for pairs of genes in these
complexes (i.e., ppc(gi{wgj)~ppc(gj{wgi)~c).
Deriving structure priors from KEGG chemical
reactions. 81 XML files describing biochemical pathways in
yeast were downloaded from ftp://ftp.genome.jp/pub/kegg/xml/
organisms/sce/. 1,061 chemical reactions and associated catalyz-
ing enzymes were parsed out, which were converted to 2,252 pairs
of metabolite–enzyme relationships (shown in Figure S7). These
relationships are stored in an adjacency matrix where a 1 in a cell
represents a direct connection between the metabolite and the
enzyme. The shortest distance dm,e from an enzyme e to a
metabolite m is calculated using the repeated matrix multiplication
algorithm. The structure prior for the gene expression of an
enzyme e affecting a metabolite concentration is related to their
shortest distance dm,e as p(m{we)!e{ldm,e. The shorter the
distance, the stronger the prior.
Averaging network models. Searching optimal BN
structures given a dataset is an NP-hard problem. We employed
an MCMC method to do local search of optimal structures. As the
method is stochastic, the resulting structure will be different for
each run. In our process, 1,000 BNs were reconstructed using
different random seeds to start the stochastic reconstruction
process. From the resulting set of 1,000 networks generated by this
process, edges that appeared in greater than 30% of the networks
were used to define a consensus network. A 30% cutoff threshold
for edge inclusion was based on our simulation study [68], where a
30% cutoff yields the best tradeoff between recall rate and
precision. The consensus network resulting from the averaging
process may not be a BN (a directed acyclic graph). To ensure the
consensus network structure is a directed acyclic graph, edges in
this consensus network were removed if and only if (1) the edge
was involved in a loop, and (2) the edge was the most weakly
supported of all edges making up the loop.
Bayesian Network for the Yeast F2 Cross
The same 3,662 informative genes used previously [13] and 56
metabolites were included in the network reconstruction process
using a BN reconstruction software program based on a previously
described algorithm [63,68] as outlined above. One thousand BNs
were reconstructed using different random seeds to start the
reconstruction process. From the resulting set of 1,000 networks
generated by this process, edges that appeared in greater than
30% of the networks were used to define a consensus network. Our
previous simulation study shows that the 30% inclusion threshold
results in a stable structure and achieves the best tradeoff between
precision and recall [68]. The histogram of percentage of
occurrences of all potential edges shows that 30% is a reasonable
cutoff threshold for inclusion (Figure S8). Edges in this consensus
network were removed if (1) the edge was involved in a loop, and
(2) the edge was the most weakly supported of all edges making up
the loop. The genetic, TFBS, and PPI data were used to derive
structure priors as previously described (details described above in
Methods) [13]. Structure priors for metabolites and genes are
derived from KEGG chemical reactions as described above.
All data and software used to construct the BNs described
herein are available at http://www.mssm.edu/research/
institutes/genomics-institute/rimbanet.
Extracting a Subnetwork from Bayesian Network
Subnetworks for sets of genes were constructed as follows.
Genes in the input set were used as seeds and the direct neighbors
of seeds were identified. Seeds and their direct neighbors define
the nodes of a given subnetwork. Links between nodes in the
subnetworks are the same as in the complete BN.
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